Full Breakdown
Arm CEO Predicts AI Will Cure Cancer Amid Chip Shortage
9/8/2026, 4:55:13 AM
AI and Cancer Cure: Vision from Arm’s Leader
Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings, told the BBC’s *Big Boss Interview* that artificial intelligence will eventually discover a cancer cure beyond human capability. He explained that while modelling a DNA marker’s interaction with cancer is “too complex” for today’s computers, feeding ever-more detailed models into increasingly sophisticated hardware will enable a solution. Haas framed the breakthrough as a matter of time, saying AI will achieve it “in our lifetime.”
Arm’s Position in the AI Surge
Arm designs the central processing units used in billions of phones, cars, smartwatches and other devices worldwide. The company’s share price peaked earlier this summer amid the AI boom, making Arm, in cash terms, the most valuable UK-based company in history. Haas also highlighted Arm’s connection to SoftBank, its Japanese majority owner, which holds a portfolio that includes investments in OpenAI.
Supply Constraints and UK Manufacturing Outlook
Despite rapid AI growth, Haas warned that a shortage of chips needed for data-centre expansion is slowing progress. He expressed skepticism that future chip fabrication could be relocated to the United Kingdom, noting current limitations in domestic manufacturing capacity.
Expert Perspective on Medical AI
Prof Chris Bakal of the Institute of Cancer Research and CEO of Sentinal4D emphasized that the decisive factor for medical AI is data quality, not sheer computing power.
Verbatim Quote
- “However, going forward, as we feed more and more of the models into these computers, and the computers get more sophisticated to run the models, they're going to solve it,” — Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings — Rene Haas, chief executive of Cambridge-based chip designer Arm Holdings
